Harmony Biosciences Holdings Inc (HRMY)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 128.31M | 119.13M | 134.22M | 160.27M | 168.41M | 154.62M | 172.81M | 186.04M |
営業利益 | 47.61M | 40.42M | 46.9M | 64.36M | 40.2M | 52.03M | 21.36M | 61.71M |
税引前収入 | 44.1M | 37.78M | 44.1M | 51.83M | 39.69M | 51.79M | 21.69M | 62.17M |
純利益 | 48.51M | 29.49M | 34.3M | 38.46M | 26.61M | 38.33M | 11.36M | 46.83M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 47.69M | 40.43M | 46.87M | 64.36M | 40.36M | 51.89M | 21.39M | 61.59M |
EBITDA | 53.68M | 46.49M | 52.97M | 70.47M | 46.32M | 58.16M | 27.41M | 67.68M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 6M | 159.74M | 305.44M | 437.86M | 582.02M |
営業利益 | -41.44M | -145.9M | 16.99M | 87.53M | 120.19M | 192.03M |
税引前収入 | -39.9M | -151.98M | -36.94M | 37.43M | 104.69M | 173.4M |
純利益 | -70.08M | -187.21M | -63.85M | 34.6M | 181.47M | 128.85M |
優先配当 | -30.19M | -35.23M | -26.9M | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.233 | -0.574 | -0.17 | 0.092 | 0.48 | 0.342 |
EBIT | -41.44M | -145.9M | -8.72M | 87.54M | 120.36M | 192.19M |
EBITDA | -41.26M | -142.69M | 27.22M | 106.37M | 143.57M | 216.39M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約